General Discussions, page-23923

I would bet you that the BAM study has minimal to no impact on the share price. We are talking about the future in the study. What we are missing are facts. That means our MOUs have to become binding and the financing has to be in place. As soon as this happens, the listed values from the BAM will provide the basis for our new market capitalization. This is very much linked to the new NPV and EBITDA. Due to the broad mass of support, RNU already has a high MC (comparatively with other graphite stocks and the currently reported numbers). We should be aware of this. The revaluation will come. But it will take time (which we will need as current graphite prices do not allow for big profits (just look at SYR)).